Diadema Partners LP Portfolio Holdings

Diadema Partners LP

  • $233 Billion
  • Q4 2024

Diadema Partners LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $233 Billion distributed in 107 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $9.05B, Abb Vie Inc. with a value of $8.89B, Teva Pharmaceutical Industries LTD with a value of $6.68B, Blueprint Medicines Corp with a value of $5.6B, and Rhythm Pharmaceuticals, Inc. with a value of $4.2B.

Examining the 13F form we can see an increase of $233B in the current position value.

Diadema Partners LP is based out at Morristown, NJ

Below you can find more details about Diadema Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $233 Billion
Healthcare: $187 Billion
ETFs: $18 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$119B
$9.05 Billion 3.88% of portfolio
160,000
Q4 2024 New
$355B
$8.89 Billion 3.81% of portfolio
50,000
Q4 2024 New
$18.9B
$6.68 Billion 2.86% of portfolio
300,000
Q4 2024 New
$5.63B
$5.6 Billion 2.4% of portfolio
64,193
Q4 2024 New
$3.21B
$4.2 Billion 1.8% of portfolio
75,000
Q4 2024 New
$231B
$3.93 Billion 1.69% of portfolio
30,000
Q4 2024 New
$11.3B
$3.89 Billion 1.67% of portfolio
56,337
Q4 2024 New
$8.63B
$3.48 Billion 1.49% of portfolio
25,276
Q4 2024 New
$1.3B
$3.32 Billion 1.43% of portfolio
60,000
Q4 2024 New
Soleno Therapeutics Inc
-
$3.24 Billion 1.39% of portfolio
-
Q4 2024 New
$775M
$2.47 Billion 1.06% of portfolio
165,965
Q4 2024 New
$2.02B
$2.3 Billion 0.99% of portfolio
53,160
Q4 2024 New
Apogee Therapeutics Inc
-
$2.29 Billion 0.98% of portfolio
-
Q4 2024 New
$1.58B
$2.21 Billion 0.95% of portfolio
131,862
Q4 2024 New
$492M
$2.08 Billion 0.89% of portfolio
505,778
Q4 2024 New
$8.57B
$1.81 Billion 0.78% of portfolio
14,719
Q4 2024 New
$4.49B
$1.44 Billion 0.62% of portfolio
47,805
Q4 2024 New
$706M
$1.38 Billion 0.59% of portfolio
114,000
Q4 2024 New
$1.98B
$1.32 Billion 0.57% of portfolio
25,900
Q4 2024 New
Vistagen Therapeutics Inc
-
$1.31 Billion 0.56% of portfolio
-
Q4 2024 New
$2.9B
$1.22 Billion 0.52% of portfolio
60,000
Q4 2024 New
$3.54B
$1.15 Billion 0.49% of portfolio
14,701
Q4 2024 New
$820M
$1.08 Billion 0.46% of portfolio
97,423
Q4 2024 New
$284M
$1.01 Billion 0.43% of portfolio
63,547
Q4 2024 New
$28.6B
$999 Million 0.43% of portfolio
8,767
Q4 2024 New
$663M
$948 Million 0.41% of portfolio
49,478
Q4 2024 New
$4.89B
$819 Million 0.35% of portfolio
10,000
Q4 2024 New
$2.84B
$775 Million 0.33% of portfolio
10,100
Q4 2024 New
$532M
$702 Million 0.3% of portfolio
90,000
Q4 2024 New
$728M
$711 Million 0.3% of portfolio
101,502
Q4 2024 New
$994M
$708 Million 0.3% of portfolio
200,000
Q4 2024 New
$109M
$674 Million 0.29% of portfolio
374,423
Q4 2024 New
$180M
$650 Million 0.28% of portfolio
698,919
Q4 2024 New
$244M
$533 Million 0.23% of portfolio
50,000
Q4 2024 New
$154M
$452 Million 0.19% of portfolio
239,019
Q4 2024 New
$23.5B
$422 Million 0.18% of portfolio
30,000
Q4 2024 New
$185M
$419 Million 0.18% of portfolio
158,023
Q4 2024 New
$35.8B
$422 Million 0.18% of portfolio
679
Q4 2024 New
$178M
$394 Million 0.17% of portfolio
156,973
Q4 2024 New
$170M
$351 Million 0.15% of portfolio
42,081
Q4 2024 New
$45.6M
$330 Million 0.14% of portfolio
197,680
Q4 2024 New
$60.4M
$312 Million 0.13% of portfolio
75,794
Q4 2024 New
$155M
$279 Million 0.12% of portfolio
50,370
Q4 2024 New
$144M
$197 Million 0.08% of portfolio
217,987
Q4 2024 New
$353M
$174 Million 0.07% of portfolio
20,000
Q4 2024 New
Sab Biotherapeutics Inc
-
$114 Million 0.05% of portfolio
-
Q4 2024 New
$453M
$101 Million 0.04% of portfolio
29,082
Q4 2024 New
Q32 Bio Inc
-
$67.8 Million 0.03% of portfolio
-
Q4 2024 New
$1.71B
$36.3 Million 0.02% of portfolio
1,359
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 107
  • Current Value $233 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 54 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email